X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (82) 82
humans (77) 77
oncology (67) 67
neuroblastoma (50) 50
neuroblastoma - genetics (42) 42
child (38) 38
infant (37) 37
male (36) 36
female (35) 35
child, preschool (33) 33
tumors (32) 32
pediatrics (31) 31
cancer (26) 26
hematology (24) 24
prognosis (23) 23
neuroblastoma - pathology (22) 22
adolescent (20) 20
children (17) 17
chromosome aberrations (14) 14
mutation (14) 14
comparative genomic hybridization (13) 13
chemotherapy (12) 12
genetics & heredity (12) 12
retrospective studies (12) 12
amplification (11) 11
neuroblastoma - mortality (11) 11
adult (10) 10
genetic aspects (10) 10
infant, newborn (10) 10
neuroblastoma - therapy (10) 10
patients (10) 10
treatment outcome (10) 10
analysis (9) 9
cell line, tumor (9) 9
copy number (9) 9
diagnosis (9) 9
gene amplification (9) 9
genes (9) 9
kaplan-meier estimate (9) 9
neuroblastoma - diagnosis (9) 9
receptor protein-tyrosine kinases - genetics (9) 9
development and progression (8) 8
expression (8) 8
gene expression profiling (8) 8
research (8) 8
reverse transcriptase polymerase chain reaction (8) 8
activating mutations (7) 7
classification (7) 7
clinical trials (7) 7
follow-up studies (7) 7
gene (7) 7
heterogeneity (7) 7
life sciences (7) 7
mycn amplification (7) 7
neuroblastoma - drug therapy (7) 7
pathology (7) 7
risk factors (7) 7
therapy (7) 7
young adult (7) 7
age (6) 6
alterations (6) 6
array-cgh (6) 6
base sequence (6) 6
disease-free survival (6) 6
high-risk neuroblastoma (6) 6
medicine and health sciences (6) 6
metastasis (6) 6
mycn (6) 6
neoplasm staging (6) 6
neuroblastoma - metabolism (6) 6
oligonucleotide array sequence analysis (6) 6
solid tumors (6) 6
surgery (6) 6
biology (5) 5
biomarkers, tumor - genetics (5) 5
breakpoints (5) 5
childrens oncology group (5) 5
clinical medicine (5) 5
combined modality therapy (5) 5
cytogenetics (5) 5
deoxyribonucleic acid--dna (5) 5
dna (5) 5
dna copy number variations (5) 5
dna, neoplasm - genetics (5) 5
gene expression (5) 5
gene expression regulation, neoplastic (5) 5
gene sequencing (5) 5
genetics (5) 5
genomes (5) 5
genomics (5) 5
health aspects (5) 5
hematology, oncology and palliative medicine (5) 5
identification (5) 5
in situ hybridization, fluorescence (5) 5
kinases (5) 5
medical prognosis (5) 5
multidisciplinary sciences (5) 5
mutation - genetics (5) 5
n-myc (5) 5
n-myc proto-oncogene protein (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 10/2008, Volume 455, Issue 7215, pp. 967 - 970
Journal Article
Nature genetics, ISSN 1061-4036, 2015, Volume 47, Issue 8, pp. 864 - 871
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2009, Volume 10, Issue 7, pp. 663 - 671
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 05/2017, Volume 109, Issue 5, p. djw305
Journal Article
Bioinformatics, ISSN 1367-4803, 2/2012, Volume 28, Issue 3, pp. 423 - 425
More and more cancer studies use next-generation sequencing (NGS) data to detect various types of genomic variation. However, even when researchers have such... 
BIOTECHNOLOGY & APPLIED MICROBIOLOGY | BIOCHEMICAL RESEARCH METHODS | MATHEMATICAL & COMPUTATIONAL BIOLOGY | Neoplasms - genetics | Humans | Alleles | Polymorphism, Single Nucleotide | Software | Loss of Heterozygosity | DNA Copy Number Variations | Index Medicus | Applications Note
Journal Article
Nature Genetics, ISSN 1061-4036, 09/2017, Volume 49, Issue 9, pp. 1408 - 1413
Neuroblastoma is a tumor of the peripheral sympathetic nervous system(1), derived from multipotent neural crest cells (NCCs). To define core regulatory... 
HUMAN GENOME | SUPER-ENHANCERS | GENE | GENETICS & HEREDITY | N-MYC | NEURONAL DIFFERENTIATION | ALK KINASE | REARRANGEMENTS | ACTIVATING MUTATIONS | PHOX2B | NEURAL CREST CELLS | Homeodomain Proteins - metabolism | Humans | Cell Lineage - drug effects | Cell Line, Tumor - classification | RNA Interference | HEK293 Cells | Gene Expression Regulation, Neoplastic - drug effects | Single-Cell Analysis | Cell Lineage - genetics | Gene Expression Regulation, Neoplastic - genetics | Neuroblastoma - genetics | Gene Expression Profiling - methods | Transcription Factors - genetics | Mice, SCID | Reverse Transcriptase Polymerase Chain Reaction | Xenograft Model Antitumor Assays - methods | Blotting, Western | Genetic Heterogeneity | Homeodomain Proteins - genetics | Mice, Knockout | Transcription Factors - metabolism | Animals | Neuroblastoma - drug therapy | Doxycycline - pharmacology | Mice, Inbred NOD | Neuroblastoma - metabolism | RNAi Therapeutics | Cancer cells | Physiological aspects | Development and progression | Genetic aspects | Neuroblastoma | Research | Genetic transcription | Transcription factors | Modules | Activator protein 1 | Principal components analysis | Genomes | Gene expression | Neural crest | Heterogeneity | Chemotherapy | Addiction | Cell lines | Cell cycle | GATA-3 protein | Norepinephrine | Mutation | Bioinformatics | Phox2b protein | Deoxyribonucleic acid--DNA | Cancer | Tumors | Index Medicus | Life Sciences | Neurons and Cognition | Biochemistry, Molecular Biology | Genomics | Neurobiology
Journal Article
Bulletin du Cancer, ISSN 0007-4551, 10/2018, Volume 105, Issue 10, pp. 918 - 924
High-risk neuroblastoma comprises nearly half of cases of neuroblastoma and the long-term survival is less than 50% despite complex and intensive treatments.... 
Immunotherapy, Anti-GD2 | High risk neuroblastoma | High dose chemotherapy | Autologous stem cell transplantation
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 04/2019, Volume 66, Issue 4, pp. e27556 - n/a
Given the biological and clinical heterogeneity of neuroblastoma, risk stratification is vital to determining appropriate treatment. Historically, most... 
neuroblastoma | risk stratification | high‐risk | biomarkers | high-risk | Heterogeneity | Population (statistical) | Historical account | Risk | Statistical methods | Neuroblastoma | Patients
Journal Article